Yuting W. Pan - Publications

Inhibition of glycosphingolipid synthesis overcomes the steric hindrance of CD30 N-glycans to augment CD30-targeted immunotherapeutic efficacy.

Journal: Cellular & molecular immunology

Published: January 19, 2026

The modified-Gustave Roussy immune score: assessing immune prognosis in advanced gastric cancer patients at baseline.

Journal: Future oncology (London, England)

Published: September 30, 2025

Pre-treatment of hyponatremia as a biomarker for poor immune prognosis in advanced or metastatic gastric cancer: A retrospective case analysis.

Journal: Human vaccines & immunotherapeutics

Published: October 16, 2024

Platelet-to-Neutrophil Ratio: A Novel Prognostic Indicator for Anti-PD-1-Based Therapy in Relapsed/Refractory Hodgkin Lymphoma and Solid Tumors.

Journal: MedComm

Published: September 06, 2024

Correction: Prognosis of patients with advanced bile tract carcinoma: assessment using the modified-Gustave Roussy Immune score (mGRIm-s) as a clinico-immunological tool.

Journal: Journal of cancer research and clinical oncology

Published: June 27, 2024

Prognostic value of a novel myeloid-to-lymphoid ratio biomarker in advanced gastric cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: May 16, 2024

Prognosis of patients with advanced bile tract carcinoma: assessment using the modified-Gustave Roussy Immune Score (mGRIm-s) as a clinico-immunological tool.

Journal: Journal of cancer research and clinical oncology

Published: March 26, 2024

Epigenetic agents plus anti-PD-1 reprogram the tumor microenvironment and restore antitumor efficacy in Hodgkin lymphoma.

Journal: Blood

Published: February 28, 2024

The Prognostic Value of the Prognostic Nutritional Index in Patients with Advanced or Metastatic Gastric Cancer Treated with Immunotherapy.

Journal: Nutrients

Published: September 13, 2023

Long-term complete remission and peripheral biomarkers in Hodgkin lymphoma patients after decitabine-plus-camrelizumab epi-immunotherapy and treatment cessation.

Journal: MedComm

Published: July 02, 2023

Prognostic Value of Tumor Size in Patients with Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-analysis.

Journal: European urology open science

Published: June 09, 2022

A composite indicator of derived neutrophil-lymphocyte ratio and lactate dehydrogenase correlates with outcomes in pancreatic carcinoma patients treated with PD-1 inhibitors.

Journal: Frontiers in oncology

Published: May 24, 2022